OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Patel on the Clinical Implications of Luspatercept Approval in MDS

May 13th 2020

Prapti Patel, MD, discusses the clinical implications of the FDA approval of luspatercept-aamt in myelodysplastic syndrome.

Dr. Carbone on the Importance of Personalizing Immunotherapy in NSCLC

May 13th 2020

David P. Carbone, MD, PhD, discusses the importance of personalizing immunotherapy for patients with non–small cell lung cancer.

Dr. Goy on the Evolution of Treatment Selection in MCL

May 13th 2020

Andre Goy, MD, MS, discusses the evolution of treatment selection in mantle cell lymphoma.

Dr. Gerson on Clinical Trial Accrual in MCL

May 13th 2020

James N. Gerson, MD, discusses clinical trial accrual in mantle cell lymphoma.

Dr. Heath on Developments in Nonmetastatic CRPC

May 13th 2020

Elisabeth I. Heath, MD, FACP, discusses developments in nonmetastatic castration-resistant prostate cancer (CRPC).

Dr. Trent on the Impact of COVID-19 on the Treatment of Rare Cancers

May 13th 2020

Jonathan C. Trent, MD, PhD, sheds light on the impact of COVID-19 on the treatment of rare cancers.

Dr. Braunstein on Updated Results of the GRIFFIN Trial in Multiple Myeloma

May 13th 2020

Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.

Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors

May 13th 2020

John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.

Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors

May 12th 2020

John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.

Dr. Patel on the Clinical Implications of Luspatercept Approval in MDS

May 12th 2020

Prapti Patel, MD, discusses the clinical implications of the FDA approval of luspatercept-aamt in myelodysplastic syndrome.

Dr. Goy on the Evolution of Treatment Selection in MCL

May 12th 2020

Andre Goy, MD, MS, discusses the evolution of treatment selection in mantle cell lymphoma.

Dr. Gerson on Clinical Trial Accrual in MCL

May 12th 2020

James N. Gerson, MD, discusses clinical trial accrual in mantle cell lymphoma.

Dr. Braunstein on Updated Results of the GRIFFIN Trial in Multiple Myeloma

May 12th 2020

Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.

Dr. Heath on Developments in Nonmetastatic CRPC

May 12th 2020

Elisabeth I. Heath, MD, FACP, discusses developments in nonmetastatic castration-resistant prostate cancer (CRPC).

Dr. Trent on the Impact of COVID-19 on the Treatment of Rare Cancers

May 12th 2020

Jonathan C. Trent, MD, PhD, sheds light on the impact of COVID-19 on the treatment of rare cancers.

Dr. Goy on Research Efforts With BTK Inhibitors in MCL

May 12th 2020

Andre Goy, MD, MS, discusses research efforts with BTK inhibitors in mantle cell lymphoma.

Dr. Smith on Safety Profiles of BTK Inhibitors in MCL

May 12th 2020

Sonali M. Smith, MD, discusses the different safety profiles of BTK inhibitors in mantle cell lymphoma.

Dr. Westin on Novel Targets in Endometrial Cancer

May 12th 2020

Shannon N. Westin, MD, MPH, discusses novel targets in endometrial cancer.

Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer

May 12th 2020

Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.

Dr. Anderson on Recent Advances With Novel Therapies in Multiple Myeloma

May 12th 2020

Larry Anderson, MD, PhD, discusses recent advances made with novel therapies in multiple myeloma.